Algorae Pharmaceuticals Limited has released a press release.
Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Story so far
Earlier from Algorae Pharmaceuticals
- Results of LCT Parkinsons trial require further analysis
- LCT files pericyte protective agent provisional patent
- Appendix 4C Quarterly Cash Flow Report 30 September 2017
- Preliminary Final Report and Financial Statements
- NTCELL continues to halt progression of Parkinsons disease
Later from Algorae Pharmaceuticals
- LCT to sell JV Shares and receive DIABECELL licence
- LCT Strategy Update
- NTCELL and Parkinsons trial update
- Preliminary Final Report and 2018 Financial Statements
- NTCELL Parkinsons trial patient data at 18 months
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals